Achieving an AIDS Transition: Preventing Infections to Sustain Treatment

Front Cover
CGD Books, Aug 31, 2012 - Business & Economics - 166 pages
0 Reviews

Five million people in poor countries are receiving AIDS treatment, but international AIDS policy is still in crisis. Donors are giving less than they had been, even though infections continue unabated, and the number of people dependent on treatment rises each year.

This book proposes a feasible medium-term objective for AIDS policy: achieving an "AIDS transition," that is, keeping AIDS deaths down by sustaining treatment while pushing new infections even lower, so that the total number of people living with HIV/AIDS begins to decline. How? Through a new, incentive-driven strategy to improve HIV prevention and a sustained effort to get the most from AIDS treatment.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Preventing Infections to Sustain Treatment Chapter 1 The Global AIDS Transition A Feasible Objective for AIDS Policy
1
Preventing Infections to Sustain Treatment Chapter 2 Using Incentives to Prevent HIV Infections
33
Preventing Infections to Sustain Treatment Chapter 3 Sustaining and Leveraging AIDS Treatment
80
Preventing Infections to Sustain Treatment Appendix A Alternative Approaches to Estimating theAverage Cost of Antiretroviral Treatment
123
Preventing Infections to Sustain Treatment Appendix B A MetaAnalysis of the Health Benefits of Early Initiation of Antiretroviral Ther apy
126
Preventing Infections to Sustain Treatment Appendix C A Model for Projecting Future AIDS Treatment Costs
130
Preventing Infections to Sustain Treatment Notes
135
Preventing Infections to Sustain Treatment References
147
Preventing Infections to Sustain Treatment Index
159
Preventing Infections to Sustain Treatment The Center for Global Development
167
Copyright

Other editions - View all

Common terms and phrases

About the author (2012)

Mead Over, a senior fellow at the Center for Global Development, is one of the world's leading experts on the economics and cost-effectiveness of HIV/AIDS prevention and treatment.

Bibliographic information